Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Fibroblast Growth Factor Receptors (FGFRs) are receptor tyrosine kinases crucial for development.
• Aberrant FGFR signaling, driven by mutations or abnormal expression, contributes significantly to oncogenesis.
• Constitutive dimerization and kinase activation of FGFRs are primary mechanisms for aberrant signaling.

Purpose of the Study:

• To review genetic alterations in FGFRs implicated in human cancer.
• To detail specific point mutations and fusion proteins involving FGFRs found in malignancies.
• To discuss the downstream signaling effects and drug resistance challenges associated with FGFR alterations.

Main Methods:

• Comprehensive review of scientific literature on FGFR mutations and fusions in cancer.
• Analysis of sequencing data from human tumors identifying FGFR genetic alterations.
• Examination of functional consequences of these alterations on cellular signaling pathways.

Main Results:

• Identification of approximately 200 specific point mutations in FGFRs across various cancers.
• Characterization of 40 distinct FGFR fusion proteins resulting from chromosomal translocations.
• Documentation of the link between specific FGFR mutations/fusions and aberrant downstream signaling.

Conclusions:

• Genetic alterations in FGFRs are prevalent in human cancers, mirroring those in developmental syndromes.
• These alterations lead to constitutive signaling, promoting tumor growth and malignancy.
• Understanding these genetic changes is critical for developing targeted therapies and overcoming drug resistance.